Prescription Medicines Division Strategy Board

The Prescription Medicines Division Strategy Board comprises fourteen representatives elected by the members of IPHA’s Prescription Medicines Division for a three year period. The Strategy Board defines the strategy and policy for the Division. Membership of the Strategy Board is open to every member company. The Strategy Board comprises:

• David Gallagher, Pfizer Healthcare Ireland  (Chairman)
• Francis Lynch, A Menarini Pharmaceuticals Ireland Ltd
• Craig Skelton, Abbott Ireland 
• Michael Byrne, Amgen Ireland Ltd
• Gerry Burke, AstraZeneca Pharmaceuticals (Ireland) Ltd
• Colette Langan, Bristol-Myers Squibb Pharmaceuticals
• Gerald Farrell, Eli Lilly & Company (Ireland) Ltd
• Sally Storey, GlaxoSmithKline
• Leisha Daly, Janssen
• Osamu Oduka, Roche Products Ireland Ltd
• Neil Boyle, MSD
  
• Loretto Callaghan, Novartis Ireland Limited
  
• Geraldine Murphy, Leo Pharma
• Mary Dickens, sanofi-aventis Ireland Ltd